(c) statistically significant expression in ovarian cancer, closely related to the OS or DFS of ovarian cancer patients (favorable or unfavorable), but with both stimulatory and inhibitory potential on immune system (eg, CD48). This evidence concerns the gene CD48 and ovarian carcinoma.